RBC Capital Remains a Hold on SAGE Therapeutics (SAGE)
RBC Capital analyst Brian Abrahams maintained a Hold rating on SAGE Therapeutics (SAGE – Research Report) on January 21 and set a price target ...
RBC Capital Keeps Their Hold Rating on Incyte (INCY)
RBC Capital analyst Brian Abrahams maintained a Hold rating on Incyte (INCY – Research Report) on January 21 and set a price target of $70.00.
bovnews8h
Why Did RBC Capital Mkts Give CF Industries Holdings, Inc. (CF) Stock Sector Perform Rating?
CF Industries Holdings, Inc. (CF) stock saw a decline, ending the day at $93.66 which represents a decrease of $-3.35 or -3.45% from the prior close of $97.01. The stock opened at $95.5 and touched a ...
RBC maintains Outperform rating on Shopify stock with $130 target
RBC Capital Markets maintained its Outperform rating on Shopify (NYSE:SHOP) with a steadfast price target of $130.00, positioning it between the analyst range of $78 to $145. RBC Capital's analysis ...
What’s wrong with the Unilever share price?
The Unilever share price looked like it was about to kick into gear... but it's idling again. Harvey Jones now wonders if his ...
Hochschild Mining Shares Tumble on 2025 Capital Expenditure, Cost Guidance
However, its 2025 costs and capital expenditure guidance exceeded analyst expectations as well as its own previous guidance. For full-year 2025, Hochschild expects capital expenditure between $197 ...